ScholarLens Back to search
2023•Research SquareOpen access

Comparison of Real-World Efficacy and Safety of Atezolizumab and Durvalumab in Combination with Chemotherapy for First-Line Treatment of Extensive-Stage Small-Cell Lung Cancer

Fumiyasu Igata, Hiroyuki Inoue, Takato Ikeda, Akira Nakao, Noriyuki Ebi, Masaki Fujita

Open full text 0 citations

Abstract

This record does not include an abstract. Use the full-text link above if available.

Open-access reader

About this research paper

What this paper is about

An abstract is not available in the OpenAlex record for this paper.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Key concepts: Atezolizumab, Durvalumab, Medicine, Chemotherapy, Oncology, Internal medicine, Lung cancer, Carboplatin

Related papers

Related paper 1Related paper 2Related paper 3
Back to paper searchBrowse research topicsOriginal source
Comparison of Real-World Efficacy and Safety of Atezolizumab and Durvalumab in Combination with Chemotherapy for First-Line Treatment of Extensive-Stage Small-Cell Lung Cancer — Research Paper | ScholarLens